30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

LDR received a letter of approval from FDA allowing commercial sale and distribution of the Mobi-C® Cervical Disc for 2-level indications. In the 2-level arm of the Investigational Device Exemption trial, Mobi-C demonstrated superiority in overall trial success vs. anterior cervical discectomy and fusion at 24 months. (LDR, 8/28/13)